A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma

Rituximab is a chimeric human-mouse anti-CD20 monoclonal antibody, which is used in the treatment of both B-cell lymphomas and rheumatic diseases. We describe a case of a previously healthy 57-year-old man developing arthritis while being treated with rituximab-CHOP chemotherapy (R-CHOP) for a non-H...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaneveld, F. H., van Vugt, R. M., de Boer, J. P., Dijkmans, B. A. C., Lems, W. F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262146/
https://www.ncbi.nlm.nih.gov/pubmed/17660934
http://dx.doi.org/10.1007/s10067-007-0704-0
_version_ 1782151411200425984
author Swaneveld, F. H.
van Vugt, R. M.
de Boer, J. P.
Dijkmans, B. A. C.
Lems, W. F.
author_facet Swaneveld, F. H.
van Vugt, R. M.
de Boer, J. P.
Dijkmans, B. A. C.
Lems, W. F.
author_sort Swaneveld, F. H.
collection PubMed
description Rituximab is a chimeric human-mouse anti-CD20 monoclonal antibody, which is used in the treatment of both B-cell lymphomas and rheumatic diseases. We describe a case of a previously healthy 57-year-old man developing arthritis while being treated with rituximab-CHOP chemotherapy (R-CHOP) for a non-Hodgkin lymphoma. The remittant arthritis developed at successively shorter time-intervals after R-CHOP administration and only improved after rituximab was removed from the chemotherapy schedule, suggesting a rituximab-related phenomenon, as extensive diagnostic testing ruled out any other diagnosis.
format Text
id pubmed-2262146
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-22621462008-03-04 A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma Swaneveld, F. H. van Vugt, R. M. de Boer, J. P. Dijkmans, B. A. C. Lems, W. F. Clin Rheumatol Case Report Rituximab is a chimeric human-mouse anti-CD20 monoclonal antibody, which is used in the treatment of both B-cell lymphomas and rheumatic diseases. We describe a case of a previously healthy 57-year-old man developing arthritis while being treated with rituximab-CHOP chemotherapy (R-CHOP) for a non-Hodgkin lymphoma. The remittant arthritis developed at successively shorter time-intervals after R-CHOP administration and only improved after rituximab was removed from the chemotherapy schedule, suggesting a rituximab-related phenomenon, as extensive diagnostic testing ruled out any other diagnosis. Springer-Verlag 2007-07-28 2008-02 /pmc/articles/PMC2262146/ /pubmed/17660934 http://dx.doi.org/10.1007/s10067-007-0704-0 Text en © Clinical Rheumatology 2007
spellingShingle Case Report
Swaneveld, F. H.
van Vugt, R. M.
de Boer, J. P.
Dijkmans, B. A. C.
Lems, W. F.
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title_full A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title_fullStr A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title_full_unstemmed A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title_short A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
title_sort 57-year-old man who developed arthritis during r-chop chemotherapy for non-hodgkin lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262146/
https://www.ncbi.nlm.nih.gov/pubmed/17660934
http://dx.doi.org/10.1007/s10067-007-0704-0
work_keys_str_mv AT swaneveldfh a57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT vanvugtrm a57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT deboerjp a57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT dijkmansbac a57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT lemswf a57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT swaneveldfh 57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT vanvugtrm 57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT deboerjp 57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT dijkmansbac 57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma
AT lemswf 57yearoldmanwhodevelopedarthritisduringrchopchemotherapyfornonhodgkinlymphoma

Ejemplares similares